Citations 1
MRX34, a liposomal miR-34 mimic, in patients with advanced solid tumors: Final dose-escalation results from a first-in-human phase I trial of microRNA therapy.
Sachdev, Jasgit C. , Ejadi, Samuel, Kim, Tae‐You, Lim, Ho Yeong , Becerra, Carlos, Bader, Andreas G. , Stoudemire, Jay, Smith, Susan, Kim, Sinil, Beg, Muhammad Shaalan , Hong, David S. , Kang, Yoon‐Koo , Brenner, Andrew Jacob , Borad, Mitesh J. , Park, Keunchil , Smith, Susan
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 2508-2508
